Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study

Federica Pinna;Bernardo Carpiniello;
2022-01-01

Abstract

Information on the off-label use of Long-Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on- vs off-label LAIs and predictors of off-label First- or Second-Generation Antipsychotic (FGA vs. SGA) LAI choice in everyday clinical practice.
2022
Inglese
BMC PSYCHIATRY
22
1
442
9
WOS:000819405000001
2-s2.0-85133223614
35773631
Esperti anonimi
internazionale
scientifica
Bipolar disorder; Long-acting injectable antipsychotics; Off-label; Personality disorder; Schizophrenia; Cross-Sectional Studies; Delayed-Action Preparations; Humans; Off-Label Use; Antipsychotic Agents
no
Armando, D'Agostino; Andrea, Aguglia; Corrado, Barbui; Francesco, Bartoli; Giuseppe, Carrà; Simone, Cavallotti; Margherita, Chirico; Edoardo G, Ostine ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
168
open
Files in This Item:
File Size Format  
D'Agostino et al, 2022.pdf

open access

Type: versione editoriale
Size 1.04 MB
Format Adobe PDF
View/Open
1.04 MB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie